Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUBUTEX SUBLINGUAL TABLETS 2 mg - HSA Drug Approval Details

Approvals/HSA/SUBUTEX SUBLINGUAL TABLETS 2 mg

Approved

THERAPEUTIC

SUBUTEX SUBLINGUAL TABLETS 2 mg

RECKITT BENCKISER HEALTHCARE (UK) LTD🇸🇬 Health Sciences Authority

Approval Date: Feb 3, 2000
Approval ID: cd68812b6a5e29a8
Company: RECKITT BENCKISER HEALTHCARE (UK) LTD
Type: Therapeutic

Approval Details

Approval Id: cd68812b6a5e29a8
Drug Name: SUBUTEX SUBLINGUAL TABLETS 2 mg
Product Name: SUBUTEX SUBLINGUAL TABLETS 2 mg
Approval Number: SIN11273P
Approval Date: 2000-02-03
Registrant: ZUELLIG PHARMA PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: N02AE01
Atc Item Name: buprenorphine
Pharma Manufacturer Name: ZUELLIG PHARMA PTE. LTD.
Company Detail Path: /organization/zuellig-pharma-pte-ltd

Active Ingredients

BUPRENORPHINE HCl EQV BUPRENORPHINE

2 mg

BUPRENORPHINE HCl EQV BUPRENORPHINE

2 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 3, 2000

Approval ID

cd68812b6a5e29a8

Type

Therapeutic

Back to HSA Approvals